Pathology Watch
Salt Lake City, US · Founded 2017 · 7 known investors
Find your way into Pathology Watch
Sign up to see every warm intro you have to Pathology Watch
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pathology Watch team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A digital pathology platform that digitizes histologic slides and distributes workload to expert dermatopathologists for remote consultation and skin cancer diagnosis.
Founders & leadership
Pathology Watch was founded in 2017 by Daniel Lambert.
Board
Investors · 7
How we know: Beni Venture Capital's portfolio page · Not right? Tell us
How we know: Harmonix Fund's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · manaventures.vc · Not right? Tell us
How we know: SpringTide Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$28.9M disclosed across 3 rounds · 2019–2021
▶$22.3MraisedMar 2023 · 88 investors · Other TechnologyRule 506(c)
- Rick StratfordDirector
- Scott MattiviExecutive Officer
- Michael TornoExecutive Officer, Director
- Austin WaltersDirector
- Arjun DesaiDirector
- Daniel LambertExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $22.3M
- Sales commissions
- $67.5K
- Placement agents
- CEROS FINANCIAL SERVICES, INC.
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$4.3MraisedMay 2020 · 23 investors · Other TechnologyRule 506(b)
- Michael TornoExecutive Officer, Director
- Daniel LambertExecutive Officer, Director
- Gregory OsmondExecutive Officer, Director
- Yiannis MonovoukasDirector
- Rick StratfordDirector
- Offering amount
- $5M
- Amount sold
- $4.3M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.3MraisedMay 2019 · 9 investors · Other TechnologyRule 506(b)
- Daniel LambertExecutive Officer, Director
- Yiannis MonovoukasDirector
- Rick StratfordDirector
- Gregory OsmondExecutive Officer, Director
- Michael TornoExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $2.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Pathology Watch.
Frequently asked questions
- What does Pathology Watch do?
- A digital pathology platform that digitizes histologic slides and distributes workload to expert dermatopathologists for remote consultation and skin cancer diagnosis.
- Who founded Pathology Watch?
- Pathology Watch was founded by Daniel Lambert in 2017.
- Who are Pathology Watch's investors?
- Pathology Watch's investors include 37 Angels, Beni Venture Capital, Gaingels, Harmonix Fund, Mana Ventures, Rock Creek Capital, SpringTide Ventures.
- How much funding has Pathology Watch raised?
- Pathology Watch has disclosed $28.9M raised across 3 rounds.
- Where is Pathology Watch headquartered?
- Pathology Watch is headquartered in Salt Lake City, US.



__Twitter.png)


